Abstract
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country.
Author supplied keywords
Cite
CITATION STYLE
Mariner-Llicer, C., Cervera, B. S., Mambuque, E., Gomes, N., Munguambe, S., Villamayor, L., … García-Basteiro, A. L. (2024). Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique. Clinical Infectious Diseases, 78(4), 842–845. https://doi.org/10.1093/cid/ciad684
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
